Literature DB >> 15921012

ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.

Zbigniew Rudzki1, Małgorzata Rucińska, Wojciech Jurczak, Aleksander B Skotnicki, Magdalena Maramorosz-Kurianowicz, Andrzej Mruk, Krystyna Piróg, Graźyna Utych, Piotr Bodzioch, Maria Srebro-Stariczyk, Iwona Włodarska, Jerzy Stachura.   

Abstract

Anaplastic lymphoma kinase (ALK)-positive diffuse large B-cell lymphoma (DLBCL) is a rare, recently defined tumor distinct in many aspects from ALK-positive anaplastic large cell lymphoma (ALCL). We present two additional cases of ALK+DLBCL recently diagnosed in our department and a review of literature. A 48-year old man presented with a large upper neck mass growing slowly over 18 months. Histologically the tumor was diagnosed as an ALK-positive diffuse large B-cell lymphoma. with plasmablastic features. Large, frequently intrasinusoidal tumor cells expressed CD138, EMA, weakly IgA and kappa, but were negative for other B-cell markers, T-cell markers and CD30. The ALK staining was cytoplasmic with the increased intensity in the Golgi area. At the diagnosis the patient manifested with the stage IIIB. Three courses of CHOP resulted in partial and only transient remission. The patient died of massive bleeding from his decomposing tumor 3 months after the diagnosis. A 49-year old man complaining of abdominal pain revealed abdominal lymphadenomegaly and a gastric infiltrate, involving the deep portions of the gastric wall. The tumor showed immunoblastic/anaplastic morphology, with some Reed-Sternberg-like cells positive for ALK. ALK immunostaining was cytoplasmic, weak in a routine immunostain, enhanced with double (proteinase + pressure cooker) antigen retrieval. FISH was consistent with the t(2;5)/nucleophosmin(NPM)-ALK rearrangement. The tumor demonstrated similar "null" B/T phenotype with positivity for IgA, lambda, EMA and LCA. The patient (stage IVB) currently undergoes chemotherapy. ALK-positive DLBCL affects mostly middle-aged men, shows generally poor but stage-dependent prognosis (at least 60% mortality rate), presents typically as a lymph node-based disseminated disease, and very rarely involves the bone marrow. Genetic studies showed that the majority of ALK+DLBCL cases are characterized by the clathrin (CLTC)-ALK fusion and in a few cases the NPM-ALK rearrangement has been found.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921012

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  7 in total

Review 1.  ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

Authors:  Kana Sakamoto; Hideki Nakasone; Yuki Togashi; Seiji Sakata; Naoko Tsuyama; Satoko Baba; Akito Dobashi; Reimi Asaka; Chien-Chen Tsai; Shih-Sung Chuang; Koji Izutsu; Yoshinobu Kanda; Kengo Takeuchi
Journal:  Int J Hematol       Date:  2016-01-18       Impact factor: 2.490

2.  Clathrin heavy chain gene fusions expressed in human cancers: analysis of cellular functions.

Authors:  Maria K E Blixt; Stephen J Royle
Journal:  Traffic       Date:  2011-03-24       Impact factor: 6.215

Review 3.  Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literature.

Authors:  Ji Chen; Xiaoli Feng; Mei Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity.

Authors:  Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2009-03-13

Review 5.  Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.

Authors:  Xiang-Nan Jiang; Bao-Hua Yu; Wei-Ge Wang; Xiao-Yan Zhou; Xiao-Qiu Li
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

6.  Relapsed anaplastic lymphoma kinase-positive large B-cell lymphoma expressed cluster of differentiation 4 and cytokeratin: An initially misdiagnosed case corrected by immunoglobulin κ locus gene rearrangement detection.

Authors:  Yunfei Shi; Xianghong Li; Yuqin Song; Lixin Zhou; Qin Feng; Ping Wang; Chen Zhang; Weiping Liu; Yanhua Bai; Yumei Lai
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

Review 7.  ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Authors:  Brady Beltran; Jorge Castillo; Renzo Salas; Pilar Quiñones; Domingo Morales; Fernando Hurtado; Luis Riva; Eric Winer
Journal:  J Hematol Oncol       Date:  2009-02-27       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.